GlassScriptPhysician profile
Paul Santiago
NPI 1114945540
$368,190.48
in general payments reported to CMS, 2019-2025
20 companies · $6,572 in 2025
The $6,572 reported for 2025 was more than what 82% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93K · 2020: $86K · 2021: $93K · 2022: $49K · 2023: $28K · 2024: $12K · 2025: $6,572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Travel and Lodging: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,750 · Food and Beverage: $3,317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,087.50 |
| Travel and Lodging | $13,535.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,750.00 |
| Food and Beverage | $3,316.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $299,565.66 | 2019-2022 | |
| Cerapedics INC. | $26,053.62 | 2022-2025 | I-Factor Peptide Enhanced Bone Graft |
| Globus Medical, INC. | $25,567.81 | 2019-2024 | Fortify / Fortify-I, Excelsiusgps Robotic Navigation System, Elsa, Elsa Al/Atp |
| Alphatec Spine, INC | $6,100.95 | 2023-2024 | Other - Miscellaneous |
| Medtronic, INC. | $4,974.69 | 2023-2025 | Stealthstation S8 Platform, Mazor X System, Cd Horizon Spinal System |
| Carbofix Spine INC | $1,666.66 | 2021 | |
| Corelink, LLC | $1,159.30 | 2019-2022 | |
| Medical Device Business Services, INC. | $642.36 | 2019 | |
| Si-Bone, INC. | $627.93 | 2019 | |
| Stryker Corporation | $350.43 | 2019-2023 | Airo, N/A |
| Medtronic USA, INC. | $344.62 | 2019 | |
| Depuy Synthes Sales INC. | $280.65 | 2019-2024 | Teligen, Fibergraft Aeridyan Matrix, Symphony |
| Abbott Laboratories | $201.39 | 2023-2024 | Eterna |
| Icotec Medical INC. | $199.18 | 2024 | Vader Pedicle System |
| Merck Sharp & Dohme LLC | $127.00 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $125.06 | 2025 | Celleraterx |
| Ulrich Medical USA, INC. | $86.66 | 2019-2024 | |
| Terumo Bct, INC. | $76.72 | 2021 | |
| Integra Lifesciences Corporation | $39.79 | 2023 | Biodoptix, Biofix, Biodrestore |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$6,155,552.32 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Santiago listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.